Pre-B-cell leukemias in Btk/Slp65-deficient mice arise independently of ongoing V(D)J recombination activity

Leukemia

Volumn 25, Issue 1, 2011, Pages 48-56

  Ta, V B T ^a   De Haan, A B ^a   De Bruijn, M J W ^a   Dingjan, G M ^a   Hendriks, R W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

ALL; Btk; c Myc; precursor B cell; Slp65

Indexed keywords

ADAPTOR PROTEIN; BRUTON TYROSINE KINASE; GENOMIC DNA; IMMUNOGLOBULIN LIGHT CHAIN; SLP65 PROTEIN; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BONE MARROW; CARCINOGENESIS; CELL TRANSFORMATION; DNA DAMAGE; FLOW CYTOMETRY; GENE ACTIVATION; GENE EXPRESSION; GENE REARRANGEMENT; GENETIC RECOMBINATION; GENOTYPE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSGENE;

EID: 78651277036     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2010.246     Document Type: Article

References (56)

1. Jung D, Giallourakis C, Mostoslavsky R, Alt FW. Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus. Annu Rev Immunol 2006; 24: 541-570.
2. Soulas-Sprauel P, Rivera-Munoz P, Malivert L, Le Guyader G, Abramowski V, Revy P et al. V(D)J and immunoglobulin class switch recombinations: a paradigm to study the regulation of DNA end-joining. Oncogene 2007; 26: 7780-7791.
3. Hardy RR. B Lymphocyte Development and Biology, 5th edn. Lippcott Williams and Wilkins: Philadelphia, 2003.
4. Roth DB. Restraining the V(D)J recombinase. Nat Rev Immunol 2003; 3: 656-666.
5. Marculescu R, Vanura K, Montpellier B, Roulland S, Le T, Navarro JM et al. Recombinase, chromosomal translocations and lymphoid neoplasia: targeting mistakes and repair failures. DNA Repair (Amst) 2006; 5: 1246-1258.
6. Curry JD, Schulz D, Guidos CJ, Danska JS, Nutter L, Nussenzweig A et al. Chromosomal reinsertion of broken RSS ends during T cell development. J Exp Med 2007; 204: 2293-2303.
7. Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 2007; 446: 758-764.
8. Mullighan CG, Downing JR. Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions. Leukemia 2009; 23: 1209-1218.
9. Merelli I, Guffanti A, Fabbri M, Cocito A, Furia L, Grazini U et al. RSSsite: a reference database and prediction tool for the identification of cryptic recombination signal sequences in human and murine genomes. Nucleic Acids Res 2010; 38(Suppl): W262-W267.
10. Raghavan SC, Swanson PC, Wu X, Hsieh CL, Lieber MR. A non-B-DNA structure at the Bcl-2 major breakpoint region is cleaved by the RAG complex. Nature 2004; 428: 88-93.
11. Hendriks RW, Kersseboom R. Involvement of SLP-65 and Btk in tumor suppression and malignant transformation of pre-B cells. Semin Immunol 2006; 18: 67-76.
12. Hendriks RW, Middendorp S. The pre-BCR checkpoint as a cell-autonomous proliferation switch. Trends Immunol 2004; 25: 249-256.
13. Melchers F. The pre-B-cell receptor: selector of fitting immuno-globulin heavy chains for the B-cell repertoire. Nat Rev Immunol 2005; 5: 578-584.
14. Herzog S, Reth M, Jumaa H. Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling. Nat Rev Immunol 2009; 9: 195-205.
15. Milne CD, Paige CJ. IL-7: a key regulator of B lymphopoiesis. Semin Immunol 2006; 18: 20-30.
16. Liu Y, Zhang L, Desiderio S. Temporal and spatial regulation of V(D)J recombination: interactions of extrinsic factors with the RAG complex. Adv Exp Med Biol 2009; 650: 157-165.
17. Conley ME, Dobbs AK, Farmer DM, Kilic S, Paris K, Grigoriadou S et al. Primary B cell immunodeficiencies: comparisons and contrasts. Annu Rev Immunol 2009; 27: 199-227.
18. Flemming A, Brummer T, Reth M, Jumaa H. The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion. Nat Immunol 2003; 4: 38-43.
19. Hayashi K, Yamamoto M, Nojima T, Goitsuka R, Kitamura D. Distinct signaling requirements for Dmu selection, IgH allelic exclusion, pre-B cell transition, and tumor suppression in B cell progenitors. Immunity 2003; 18: 825-836.
20. Kersseboom R, Middendorp S, Dingjan GM, Dahlenborg K, Reth M, Jumaa H et al. Bruton's tyrosine kinase cooperates with the B cell linker protein SLP-65 as a tumor suppressor in Pre-B cells. J Exp Med 2003; 198: 91-98.
21. Middendorp S, Zijlstra AJ, Kersseboom R, Dingjan GM, Jumaa H, Hendriks RW. Tumor suppressor function of Bruton tyrosine kinase is independent of its catalytic activity. Blood 2005; 105: 259-265.
22. Jumaa H, Bossaller L, Portugal K, Storch B, Lotz M, Flemming A et al. Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia. Nature 2003; 423: 452-456.
23. Klein F, Feldhahn N, Harder L, Wang H, Wartenberg M, Hofmann WK et al. The BCR-ABL1 kinase bypasses selection for the expression of a pre-B cell receptor in pre-B acute lympho-blastic leukemia cells. J Exp Med 2004; 199: 673-685.
24. Imai C, Ross ME, Reid G, Coustan-Smith E, Schultz KR, Pui CH et al. Expression of the adaptor protein BLNK/SLP-65 in childhood acute lymphoblastic leukemia. Leukemia 2004; 18: 922-925.
25. Nakayama J, Yamamoto M, Hayashi K, Satoh H, Bundo K, Kubo M et al. BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3. Blood 2009; 113: 1483-1492.
26. Trageser D, Iacobucci I, Nahar R, Duy C, von Levetzow G, Klemm L et al. Pre-B cell receptor-mediated cell cycle arrest in Philadelphia chromosome-positive acute lymphoblastic leukemia requires IKAROS function. J Exp Med 2009; 206: 1739-1753.
27. Eischen CM, Weber JD, Roussel MF, Sherr CJ, Cleveland JL. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev 1999; 13: 2658-2669.
28. Ta VB, de Bruijn MJ, ter Brugge PJ, van Hamburg JP, Diepstraten HJ, van Loo PF et al. Malignant transformation of Slp65-deficient pre-B cells involves disruption of the Arf-Mdm2-p53 tumor suppressor pathway. Blood 2010; 115: 1385-1393.
29. Nussenzweig MC, Schmidt EV, Shaw AC, Sinn E, Campos-Torres J, Mathey-Prevot B et al. A human immunoglobulin gene reduces the incidence of lymphomas in c-Myc-bearing transgenic mice. Nature 1988; 336: 446-450.
30. Nepal RM, Zaheen A, Basit W, Li L, Berger SA, Martin A. AID and RAG1 do not contribute to lymphomagenesis in Emu c-myc transgenic mice. Oncogene 2008; 27: 4752-4756.
31. Habib T, Park H, Tsang M, de Alboran IM, Nicks A, Wilson L et al. Myc stimulates B lymphocyte differentiation and amplifies calcium signaling. J Cell Biol 2007; 179: 717-731.
32. Wen R, Chen Y, Bai L, Fu G, Schuman J, Dai X et al. Essential role of phospholipase C gamma 2 in early B-cell development and Myc-mediated lymphomagenesis. Mol Cell Biol 2006; 26: 9364-9376.
33. Sprangers M, Feldhahn N, Liedtke S, Jumaa H, Siebert R, Muschen M. SLP65 deficiency results in perpetual V(D)J recombi-nase activity in pre-B-lymphoblastic leukemia and B-cell lympho-ma cells. Oncogene 2006; 25: 5180-5186.
34. Hendriks RW, de Bruijn MF, Maas A, Dingjan GM, Karis A, Grosveld F. Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage. Embo J 1996; 15: 4862-4872.
35. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 1992; 68: 869-877.
36. Russell DM, Dembic Z, Morahan G, Miller JF, Burki K, Nemazee D. Peripheral deletion of self-reactive B cells. Nature 1991; 354: 308-311.
37. Jumaa H, Wollscheid B, Mitterer M, Wienands J, Reth M, Nielsen PJ. Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65. Immunity 1999; 11: 547-554.
38. Middendorp S, Dingjan GM, Hendriks RW. Impaired precursor B cell differentiation in Bruton's tyrosine kinase-deficient mice. J Immunol 2002; 168: 2695-2703.
39. Nemazee DA, Burki K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature 1989; 337: 562-566.
40. Jumaa H, Mitterer M, Reth M, Nielsen PJ. The absence of SLP65 and Btk blocks B cell development at the preB cell receptor-positive stage. Eur J Immunol 2001; 31: 2164-2169.
41. Blunt T, Finnie NJ, Taccioli GE, Smith GC, Demengeot J, Gottlieb TM et al. Defective DNA-dependent protein kinase activity is linked to V(D)J recombination and DNA repair defects associated with the murine scid mutation. Cell 1995; 80: 813-823.
42. Bosma GC, Fried M, Custer RP, Carroll A, Gibson DM, Bosma MJ. Evidence of functional lymphocytes in some (leaky) scid mice. J Exp Med 1988; 167: 1016-1033.
43. Gao Y, Chaudhuri J, Zhu C, Davidson L, Weaver DT, Alt FW. A targeted DNA-PKcs-null mutation reveals DNA-PK-independent functions for KU in V(D)J recombination. Immunity 1998; 9: 367-376.
44. Taccioli GE, Amatucci AG, Beamish HJ, Gell D, Xiang XH, Torres Arzayus MI et al. Targeted disruption of the catalytic subunit of the DNA-PK gene in mice confers severe combined immunodeficiency and radiosensitivity. Immunity 1998; 9: 355-366.
45. Melamed D, Benschop RJ, Cambier JC, Nemazee D. Developmental regulation of B lymphocyte immune tolerance compartmentalizes clonal selection from receptor selection. Cell 1998; 92: 173-182.
46. Melamed D, Kench JA, Grabstein K, Rolink A, Nemazee D. A functional B cell receptor transgene allows efficient IL-7-independent maturation of B cell precursors. J Immunol 1997; 159: 1233-1239.
47. Middendorp S, Hendriks RW. Cellular maturation defects in Bruton's tyrosine kinase-deficient immature B cells are amplified by premature B cell receptor expression and reduced by receptor editing. J Immunol 2004; 172: 1371-1379.
48. Morrow MA, Lee G, Gillis S, Yancopoulos GD, Alt FW. Interleukin-7 induces N-myc and c-myc expression in normal precursor B lymphocytes. Genes Dev 1992; 6: 61-70.
49. Arakawa H, Takeda S. Early expression of Ig mu chain from a transgene significantly reduces the duration of the pro-B stage but does not affect the small pre-B stage. Int Immunol 1996; 8: 1319-1328.
50. Duy C, Yu JJ, Nahar R, Swaminathan S, Kweon SM, Polo JM et al. BCL6 is critical for the development of a diverse primary B cell repertoire. J Exp Med 2010; 207: 1209-1221.
51. Schebesta M, Pfeffer PL, Busslinger M. Control of pre-BCR signaling by Pax5-dependent activation of the BLNK gene. Immunity 2002; 17: 473-485.
52. Meixlsperger S, Kohler F, Wossning T, Reppel M, Muschen M, Jumaa H. Conventional light chains inhibit the autonomous signaling capacity of the B cell receptor. Immunity 2007; 26: 323-333.
53. Kohler F, Hug E, Eschbach C, Meixlsperger S, Hobeika E, Kofer J et al. Autoreactive B cell receptors mimic autonomous pre-B cell receptor signaling and induce proliferation of early B cells. Immunity 2008; 29: 912-921.
54. Ubelhart R, Bach MP, Eschbach C, Wossning T, Reth M, Jumaa H. N-linked glycosylation selectively regulates autonomous precursor BCR function. Nat Immunol 2010; 11: 759-765.
55. Williams CJ, Grandal I, Vesprini DJ, Wojtyra U, Danska JS, Guidos CJ. Irradiation promotes V(D)J joining and RAG-dependent neoplastic transformation in SCID T-cell precursors. Mol Cell Biol 2001; 21: 400-413.
56. Zhu C, Mills KD, Ferguson DO, Lee C, Manis J, Fleming J et al. Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell 2002; 109: 811-821.